Cymbalta (duloxetine) is approved to treat five conditions: major depressive disorder, generalized anxiety disorder, diabetic nerve pain, fibromyalgia, and chronic musculoskeletal pain. It belongs to a class of medications called SNRIs, which work by increasing the activity of two chemical messengers in the brain, serotonin and norepinephrine. This dual action is what makes it useful for both mood disorders and certain types of pain.
How Cymbalta Works in the Brain and Body
Serotonin and norepinephrine are naturally occurring chemicals that help regulate mood, anxiety, and the way your body processes pain signals. Cymbalta blocks the reabsorption of both chemicals, keeping them active longer in the spaces between nerve cells. For depression and anxiety, this means more of these mood-regulating chemicals are available where they’re needed.
The pain relief works through a different pathway. Cymbalta strengthens a set of nerves that run down from the brain into the spinal cord, acting like a volume dial for pain signals. These descending nerves suppress excessive pain input before it reaches the brain, which is why the same medication can treat both a mood disorder and chronic pain. As a secondary effect, blocking norepinephrine reabsorption also raises levels of dopamine in the prefrontal cortex, a brain area involved in motivation, focus, and emotional regulation.
Major Depressive Disorder
Cymbalta is approved for treating major depression in adults. Most people start at 30 to 60 mg per day, and the standard effective dose is 60 mg once daily. While higher doses up to 120 mg have shown effectiveness in clinical trials, there’s no strong evidence that going above 60 mg provides additional benefit for most people.
Improvement typically begins within two to four weeks, but it can take a full six weeks to feel the medication’s complete effect. If you haven’t noticed any change after six weeks, that’s a reasonable point to revisit the treatment plan with your prescriber.
Generalized Anxiety Disorder
Cymbalta is approved for generalized anxiety disorder in adults and in children aged 7 and older, making it one of the few SNRIs with a pediatric indication for anxiety. The recommended dose for most patients is 60 mg once daily, sometimes starting at 30 mg for the first week to ease into the medication. As with depression, doses above 60 mg haven’t been shown to add meaningful benefit for the majority of people.
The timeline for anxiety relief mirrors what’s seen with depression. Some people notice a shift within two to four weeks, though giving the medication at least six weeks before judging its effectiveness is a reasonable expectation.
Diabetic Nerve Pain
Nerve damage caused by diabetes, known as diabetic peripheral neuropathy, often produces burning, tingling, or shooting pain in the hands and feet. Cymbalta is one of the first-line treatments for this type of pain, and the evidence behind it is solid. A large Cochrane review found that at 60 mg daily, patients were about 1.65 times more likely to achieve a 50% reduction in pain compared to placebo over 12 weeks.
To put that in practical terms, for every six people treated with Cymbalta for diabetic nerve pain, one person will experience that level of meaningful pain relief who wouldn’t have on a placebo. That may sound modest, but in chronic pain treatment, where many medications struggle to outperform placebo significantly, it represents a clinically meaningful effect. The same Cochrane review found that 20 mg daily was not effective, so adequate dosing matters. Pain relief from nerve conditions can also take longer to develop than mood improvements, so patience is important.
Fibromyalgia
Fibromyalgia causes widespread pain, fatigue, and heightened sensitivity to touch and pressure. Cymbalta is one of only three medications with FDA approval specifically for fibromyalgia, and it’s approved for adults and adolescents aged 13 and older.
Clinical trial data from the FDA’s review showed that Cymbalta at 60 mg daily produced significant improvement in pain scores compared to placebo over three months of treatment. Some patients experienced reduced pain as early as the first week, and that improvement persisted through the study period. Higher doses (120 mg daily) also showed pain improvement, but with more side effects and no clear advantage over the standard 60 mg dose. Patients also reported improvement in their overall sense of well-being at the three-month mark.
The longer-term picture is less clear. The FDA review noted that when researchers accounted for people who dropped out of trials, the evidence for sustained pain relief beyond three months weakened. By 12 months, there was no strong evidence that the pain benefit remained clinically meaningful. This doesn’t mean it stops working for everyone, but it’s worth knowing that fibromyalgia treatment often requires ongoing adjustment. Cymbalta did not show significant improvement in fatigue or overall functional scores like the ability to carry out daily activities, which are core complaints for many fibromyalgia patients.
Chronic Musculoskeletal Pain
Cymbalta’s fifth approved use covers chronic musculoskeletal pain, primarily osteoarthritis and chronic low back pain. These are conditions where pain persists for months or longer and doesn’t always respond well to standard painkillers alone. The approval was based on trials measuring the percentage of patients who achieved at least a 30% or 50% reduction in their average daily pain.
This indication makes Cymbalta a particularly versatile option for people who have both a mood disorder and chronic pain, since a single medication can address both. It’s not a replacement for physical therapy or other non-drug approaches, but it can be a useful addition when pain is interfering with daily life and hasn’t responded to other treatments.
What to Expect When Starting
Regardless of the condition being treated, most prescribers start Cymbalta at 30 mg daily for the first week. This ramp-up period lets your body adjust and reduces the chance of early side effects like nausea, which is one of the most commonly reported issues in the first few days. After that initial week, the dose is typically increased to 60 mg once daily.
The timeline for noticing improvement depends on what you’re treating. Mood and anxiety symptoms tend to respond within two to four weeks, while pain conditions, especially nerve pain, can take longer. Six weeks is a reasonable window to evaluate whether the medication is working. Cymbalta is taken as a capsule, usually once a day, and should be swallowed whole rather than crushed or chewed since the coating controls how the medication is released.
One thing that catches many people off guard is that stopping Cymbalta abruptly can cause withdrawal-like symptoms, including dizziness, irritability, and a sensation sometimes described as “brain zaps.” Tapering off gradually under a prescriber’s guidance is standard practice for this reason.